Clinical Trials
2
Active:2
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study of iPS Cell-derived Cardiomyocyte Spheroids (HS-001) in Patients With Heart Failure (LAPiS Study)
Phase 1
Active, not recruiting
- Conditions
- Ischemic Heart DiseaseHeart Failure
- Interventions
- Biological: HS-001 CSDevice: HS-001-D needle, HS-001-D Adaptor
- First Posted Date
- 2021-06-30
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Heartseed Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT04945018
- Locations
- 🇯🇵
St. Marianna University Hospital, Kawasaki, Japan
🇯🇵Saitama Medical University International Medical Center, Saitama, Japan
🇯🇵Juntendo University Hospital, Tokyo, Japan
News
No news found